Literature DB >> 33359150

Validation of a Histologic Scoring Index for C3 Glomerulopathy.

Fernando Caravaca-Fontán1, Hernando Trujillo2, Marina Alonso3, Montserrat Díaz-Encarnación4, Virginia Cabello5, Gema Ariceta6, Luis F Quintana7, Helena Marco8, Xoana Barros9, Natalia Ramos10, Nuria Rodríguez-Mendiola11, Sonia Cruz12, Gema Fernández-Juárez13, Eva Rodríguez14, Francisco de la Cerda15, Ana Pérez de José16, Inmaculada López17, Loreto Fernández18, Vanessa Pérez Gómez19, Ana Ávila20, Luis Bravo21, Javier Lumbreras22, Natalia Allende23, Maria Dolores Sanchez de la Nieta24, Teresa Olea25, Marta Melgosa26, Ana Huerta27, Rosa Miquel28, Carmen Mon29, Gloria Fraga30, Alberto de Lorenzo31, Juliana Draibe32, Fayna González33, Amir Shabaka34, Maria Luisa Illescas35, Consuelo Calvo36, Victoria Oviedo37, Iara Da Silva4, Elena Goicoechea de Jorge38, Francisco Caravaca39, Manuel Praga40.   

Abstract

RATIONALE &
OBJECTIVE: A previous study that evaluated associations of kidney biopsy findings with disease progression in patients with C3 glomerulopathy (C3G) proposed a prognostic histologic index (C3G-HI) that has not yet been validated. Our objective was to validate the performance of the C3G-HI in a new patient population. STUDY
DESIGN: Multicenter, retrospective cohort study. SETTING & PARTICIPANTS: 111 patients fulfilling diagnostic criteria of C3G between January 1995 and December 2019, from 33 nephrology departments belonging to the Spanish Group for the Study of Glomerular Diseases (GLOSEN). PREDICTORS: Demographic, clinical parameters, C3G-HI total activity score, and the C3G-HI total chronicity score. OUTCOME: Time to kidney failure. ANALYTICAL APPROACH: Intraclass correlation coefficients and κ statistic were used to summarize inter-rater reproducibility for assessment of histopathology in kidney biopsies. The nonlinear relationships of risk of kidney failure with the total activity score and total chronicity score were modeled using Cox proportional hazards analysis that incorporated cubic splines.
RESULTS: The study group included 93 patients with C3 glomerulonephritis and 18 with dense-deposit disease. Participants had an overall meanage of 35±22 (SD) years. Forty-eight patients (43%) developed kidney failure after a mean follow-up of 65±27 months. The overall inter-rater reproducibility was very good for the total activity score (intraclass correlation coefficient [ICC]=0.63) and excellent for total chronicity score (ICC=0.89). Baseline estimated glomerular filtration rate (eGFR), 24-hour proteinuria, and treatment with immunosuppression were the main determinants of kidney failure in a model with only clinical variables. Only tubular atrophy and interstitial fibrosis were identified as predictors in a model with histological variables. When the total activity score and total chronicity score were added to the model, only the latter was identified as an independent predictor of kidney failure. LIMITATIONS: Only a subset of the kidney biopsies was centrally reviewed. Residual confounding.
CONCLUSIONS: We validated the performance of C3G-HI as a predictor of kidney failure in patients with C3G. The total chronicity score was the principal histologic correlate of kidney failure.
Copyright © 2020 National Kidney Foundation, Inc. Published by Elsevier Inc. All rights reserved.

Entities:  

Keywords:  C3 glomerulonephritis (C3GN); C3 glomerulopathy (C3G); dense-deposit disease (DDD); disease prognosis; histologic index; intraclass correlations; kidney biopsy; kidney failure; kidney survival; prognostic tool; total activity Score; total chronicity score

Year:  2020        PMID: 33359150     DOI: 10.1053/j.ajkd.2020.11.011

Source DB:  PubMed          Journal:  Am J Kidney Dis        ISSN: 0272-6386            Impact factor:   8.860


  7 in total

1.  Association of Histologic Parameters with Outcome in C3 Glomerulopathy and Idiopathic Immunoglobulin-Associated Membranoproliferative Glomerulonephritis.

Authors:  Hannah J Lomax-Browne; Nicholas R Medjeral-Thomas; Sean J Barbour; Jack Gisby; Heedeok Han; Andrew S Bomback; Fernando C Fervenza; Thomas H Cairns; Richard Szydlo; Sven-Jean Tan; Stephen D Marks; Aoife M Waters; Gerald B Appel; Vivette D D'Agati; Sanjeev Sethi; Cynthia C Nast; Ingeborg Bajema; Charles E Alpers; Agnes B Fogo; Christoph Licht; Fadi Fakhouri; Daniel C Cattran; James E Peters; H Terence Cook; Matthew C Pickering
Journal:  Clin J Am Soc Nephrol       Date:  2022-07       Impact factor: 10.614

2.  Epidemiology and clinicopathological characteristics of native kidney disease in children in Flanders, Belgium.

Authors:  Dries Deleersnijder; Noël Knops; Dominique Trouet; Koen Van Hoeck; Sevasti Karamaria; Johan Vande Walle; Reiner Mauel; Louise Cools; Gert Meeus; Amélie Dendooven; Johan De Meester; Wim Laurens; Ben Sprangers
Journal:  Pediatr Nephrol       Date:  2022-10-13       Impact factor: 3.651

3.  IgA Nephropathy Is the Most Common Underlying Disease in Patients With Anticoagulant-Related Nephropathy.

Authors:  Hernando Trujillo; Justo Sandino; Teresa Cavero; Fernando Caravaca-Fontán; Eduardo Gutiérrez; Ángel M Sevillano; Amir Shabaka; Gema Fernández-Juárez; Pablo Rodríguez Doyágüez; Rocío Gimena Muñoz; Leonardo Calle García; Virginia Cabello; José Manuel Muñoz-Terol; Ana García Santiago; Oscar Toldos; Juan Antonio Moreno; Manuel Praga
Journal:  Kidney Int Rep       Date:  2022-01-19

4.  Living well with kidney disease by patient and care-partner empowerment: kidney health for everyone everywhere.

Authors:  Kamyar Kalantar-Zadeh; Philip Kam-Tao Li; Ekamol Tantisattamo; Latha Kumaraswami; Vassilios Liakopoulos; Siu-Fai Lui; Ifeoma Ulasi; Sharon Andreoli; Alessandro Balducci; Sophie Dupuis; Tess Harris; Anne Hradsky; Richard Knight; Sajay Kumar; Maggie Ng; Alice Poidevin; Gamal Saadi; Allison Tong
Journal:  Clin Exp Nephrol       Date:  2021-03-15       Impact factor: 2.801

5.  Living Well with Kidney Disease by patient and care-partner empowerment: Kidney Health for Everyone Everywhere.

Authors:  Kamyar Kalantar-Zadeh; Philip Kam-Tao Li; Ekamol Tantisattamo; Latha Kumaraswami; Vassilios Liakopoulos; Siu-Fai Lui; Ifeoma Ulasi; Sharon Andreoli; Alessandro Balducci; Sophie Dupuis; Tess Harris; Anne Hradsky; Richard Knight; Sajay Kumar; Maggie Ng; Alice Poidevin; Gamal Saadi; Allison Tong
Journal:  J Nephrol       Date:  2021-03-06       Impact factor: 3.902

6.  Development and validation of a nomogram to predict kidney survival at baseline in patients with C3 glomerulopathy.

Authors:  Fernando Caravaca-Fontán; Marta Rivero; Teresa Cavero; Montserrat Díaz-Encarnación; Virginia Cabello; Gema Ariceta; Luis F Quintana; Helena Marco; Xoana Barros; Natalia Ramos; Nuria Rodríguez-Mendiola; Sonia Cruz; Gema Fernández-Juárez; Adela Rodríguez; Ana Pérez de José; Cristina Rabasco; Raquel Rodado; Loreto Fernández; Vanessa Pérez-Gómez; Ana Ávila; Luis Bravo; Natalia Espinosa; Natalia Allende; Maria Dolores Sanchez de la Nieta; Eva Rodríguez; Teresa Olea; Marta Melgosa; Ana Huerta; Rosa Miquel; Carmen Mon; Gloria Fraga; Alberto de Lorenzo; Juliana Draibe; Fayna González; Amir Shabaka; Maria Esperanza López-Rubio; María Ángeles Fenollosa; Luis Martín-Penagos; Iara Da Silva; Juana Alonso Titos; Santiago Rodríguez de Córdoba; Elena Goicoechea de Jorge; Manuel Praga
Journal:  Clin Kidney J       Date:  2022-04-28

7.  Kidney biopsy chronicity grading in antineutrophil cytoplasmic antibody-associated vasculitis.

Authors:  Marta Casal Moura; Fernando C Fervenza; Ulrich Specks; Sanjeev Sethi
Journal:  Nephrol Dial Transplant       Date:  2022-08-22       Impact factor: 7.186

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.